Market Place
Sourcing Support
All News #Library
Biotech
AstraZeneca completes acquisition of Icosavax
21 Feb 2024 //
INDIAN PHARMA POST
AstraZeneca Buys into RSV Vaccine Market with Potential $1.1B Icosavax Purchase
13 Dec 2023 //
BIOSPACE
Icosavax Announces Positive Topline Interim Phase 2 Results for IVX-A12
12 Dec 2023 //
PRESS RELEASE
Icosavax to Participate in the Jefferies London Healthcare Conference
08 Nov 2023 //
GLOBENEWSWIRE
Icosavax to Participate in Cantor Fitzgerald Global Healthcare Conference 2023
19 Sep 2023 //
GLOBENEWSWIRE
Icosavax Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
Icosavax Reports Positive Durability Data for VLP Vaccine Candidate IVX-121
08 Aug 2023 //
GLOBENEWSWIRE
Icosavax Initiates Phase 2 Trial of IVX-A12 Against RSV and hMPV in Older Adults
20 Jun 2023 //
GLOBENEWSWIRE
Icosavax pushes forward combo RSV-hMPV vaccine
23 May 2023 //
ENDPTS
Icosavax Announces Positive Topline Interim Phase 1 Results for IVX-A12
22 May 2023 //
PRESS RELEASE
Icosavax Announces Phase 1 Results for Bivalent VLP Vaccine Candidate IVX-A12
22 May 2023 //
GLOBENEWSWIRE
Icosavax Announces $67.8 Million Registered Direct Offering of Common Stock
22 May 2023 //
GLOBENEWSWIRE
Icosavax Granted FDA Fast Track Designation for IVX-A12
21 Feb 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.